BACKGROUND: As shown earlier by the authors via Western blot analysis, open (OS) but not laparoscopic surgery (LS) induces a qualitative decrease in plasma insulin-like growth factor-binding protein 3 (IGFBP-3) levels on postoperative day 1 (POD 1). Intact IGFBP-3 has tumor suppressive effects, but its degradation products do not. Enzyme linked immunoassay (ELISA) inevitably measures both. In this study, using a novel combined Western blot and ELISA analysis method, precise plasma levels of intact IGFBP-3 on POD2 after open and closed colorectal cancer resection (stage I-III) were determined. METHODS: This study included 15 OS patients with a mean incision length of 26.7 +/- 15.5 cm and 16 LS patients with a mean incision length of 5.3 +/- 3.1 cm. Intact IGFBP-3 levels were determined via ELISA and Western blot analysis in plasma collected preoperatively and postoperatively. RESULTS: In the OS patients, the mean preoperative concentration of intact 43-45 kDa IGFBP-3 protein was 1920 +/- 1430 ng/ml. It decreased dramatically on POD2 to 355 +/- 545 ng/ml (p < 0.005). In the LS group, no significant difference was noted between the preoperative level (1305 +/- 807 ng/ml) and the POD2 level (922 + 714 ng/ml). CONCLUSIONS: Open cancer resection, unlike its minimally invasive alternative, induces a dramatic decrease in concentration of intact IGFBP-3, which may have important implications with regard to colon cancer recurrence.
BACKGROUND: As shown earlier by the authors via Western blot analysis, open (OS) but not laparoscopic surgery (LS) induces a qualitative decrease in plasma insulin-like growth factor-binding protein 3 (IGFBP-3) levels on postoperative day 1 (POD 1). Intact IGFBP-3 has tumor suppressive effects, but its degradation products do not. Enzyme linked immunoassay (ELISA) inevitably measures both. In this study, using a novel combined Western blot and ELISA analysis method, precise plasma levels of intact IGFBP-3 on POD2 after open and closed colorectal cancer resection (stage I-III) were determined. METHODS: This study included 15 OS patients with a mean incision length of 26.7 +/- 15.5 cm and 16 LS patients with a mean incision length of 5.3 +/- 3.1 cm. Intact IGFBP-3 levels were determined via ELISA and Western blot analysis in plasma collected preoperatively and postoperatively. RESULTS: In the OS patients, the mean preoperative concentration of intact 43-45 kDa IGFBP-3 protein was 1920 +/- 1430 ng/ml. It decreased dramatically on POD2 to 355 +/- 545 ng/ml (p < 0.005). In the LS group, no significant difference was noted between the preoperative level (1305 +/- 807 ng/ml) and the POD2 level (922 + 714 ng/ml). CONCLUSIONS: Open cancer resection, unlike its minimally invasive alternative, induces a dramatic decrease in concentration of intact IGFBP-3, which may have important implications with regard to colon cancer recurrence.
Authors: A G Renehan; J E Painter; D O'Halloran; W S Atkin; C S Potten; S T O'Dwyer; S M Shalet Journal: J Clin Endocrinol Metab Date: 2000-09 Impact factor: 5.958
Authors: J Ma; M N Pollak; E Giovannucci; J M Chan; Y Tao; C H Hennekens; M J Stampfer Journal: J Natl Cancer Inst Date: 1999-04-07 Impact factor: 13.506
Authors: Nabeel A Arain; Luisangel Rondon; Deborah C Hogg; Jeffrey A Cadeddu; Richard Bergs; Raul Fernandez; Daniel J Scott Journal: Surg Endosc Date: 2012-05-31 Impact factor: 4.584
Authors: I Kirman; S Jain; V Cekic; A Belizon; E Balik; P Sylla; T Arnell; K A Forde; R L Whelan Journal: Surg Endosc Date: 2006-01-21 Impact factor: 4.584
Authors: Avraham Belizon; Emre Balik; Daniel L Feingold; Marc Bessler; Tracey D Arnell; Kenneth A Forde; Patrick K Horst; Suvinit Jain; Vesna Cekic; Irena Kirman; Richard L Whelan Journal: Ann Surg Date: 2006-11 Impact factor: 12.969
Authors: E Lezoche; M Guerrieri; A De Sanctis; R Campagnacci; M Baldarelli; G Lezoche; A M Paganini Journal: Surg Endosc Date: 2006-02-27 Impact factor: 4.584
Authors: H M C Shantha Kumara; A Hoffman; I Y Kim; D Feingold; N Dujovny; M Kalady; M Kallady; M Luchtefeld; R L Whelan Journal: Surg Endosc Date: 2008-09-24 Impact factor: 4.584
Authors: A Belizon; E Balik; P Horst; D Feingold; T Arnell; T Azarani; V Cekic; R Skitt; S Kumara; R L Whelan Journal: Surg Endosc Date: 2008-01-18 Impact factor: 4.584
Authors: Mario Guerrieri; Roberto Campagnacci; Angelo De Sanctis; Giovanni Lezoche; Paolo Massucco; Massimo Summa; Rosaria Gesuita; Lorenzo Capussotti; Giuseppe Spinoglio; Emanuele Lezoche Journal: Surg Today Date: 2012-08-19 Impact factor: 2.549